Onyx Healthcare Inc. (6569.TWO) has a MoatMap StockRank of 46/100 based on Quality (60/100), Value (35/100), and Momentum (38/100) factor scores. The current signal is HOLD. Onyx Healthcare produces specialized medical computing products, but it lacks the scale, brand power, and deep competitive moat required to survive our quality filters. The stock does not align with any of our high-conviction macro themes.
Onyx Healthcare Inc. designs and manufactures medical-grade computing systems, including clinical assistant terminals, surgical monitors, and mobile nursing carts. The company is a leading global provider in the smart healthcare IT sector, holding extensive medical safety certifications (FDA, CE) that act as high barriers to entry. Its competitive advantage is driven by specialized R&D in infection-control hardware and long-term partnerships with global medical device OEMs.
| Price | $3.57 |
| Market Cap | $125M |
| P/E (TTM) | 38.85 |
| Price/Book | 2.77 |
| Return on Equity | 7.2% |
| Return on Invested Capital | 7.2% |
| Debt/Equity | 18.65 |
| Gross Margin | 33.0% |
| Operating Margin | 8.7% |
| Revenue Growth | -17.5% |
| Dividend Yield | 3.9% |
| Free Cash Flow | $75K |
Onyx Healthcare Inc. operates in the Health Information Services industry, part of the Healthcare sector (Taiwan).